Count on at least another 1.5 years

Discussion in 'Chelsea Therapeutics' started by Anonymous, Apr 1, 2012 at 1:33 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    This is no ordinary delay. The FDA is requesting an additional study and this will take time and money in addition to other hold ups. There is absolutely no way a new company like this would be able to keep all the managers they hired for that long. Obviously, they will all start to find other opportunities if they are smart.
     

  2. Anonymous

    Anonymous Guest

    You have no idea what you are talking about. The FDA has not met with Chelsea management yet to outline what is needed. Go spread your lies somewhere else.
     
  3. Anonymous

    Anonymous Guest

    FDA/GEstapo will take their time , "ve vill investigaate, yoor produccttt! Ve vill make yooo give us the rigth information!!!
     
  4. Anonymous

    Anonymous Guest

    I am sorry, but you are delusional. Nothing moves that fast and THEY do want another study especially since it will be highlighted with a black box warning. No lies just reality.
     
  5. Anonymous

    Anonymous Guest

    There is an ongoing study.
     
  6. Anonymous

    Anonymous Guest

    You're right....ongoing study...............years.........more years........even more years.....
     
  7. Anonymous

    Anonymous Guest

    The ongoing study will be done in a few weeks...
     
  8. Anonymous

    Anonymous Guest

    approval would come 1st qtr 2013 at the earliest....about 10 more months.
     
  9. Anonymous

    Anonymous Guest



    READ THis and SHUT THE FUCK UP-STUPID


    Chelsea Therapeutics International Ltd. (CHTP) fell as much as 29 percent after failing to get the U.S. regulatory approval needed to bring its first drug to market.

    The Food and Drug Administration wants more data on Northera, a medicine intended to treat a cause of dizziness and fainting in people with nervous-system disorders, Chelsea said in a statement yesterday. Chelsea tumbled 29 percent to $2.62 at the close in New York, the biggest single-day decline since Feb. 13.

    The FDA requested information from an additional study of Northera, which can curb drops in blood pressure, Chelsea said. The Charlotte, North Carolina-based company said it’s conducting a clinical trial that may provide the additional data about the drug’s “efficacy and durability” sought by the FDA.

    The trial “may not be sufficient for approval” because the FDA is likely to ask for more information about a range of symptoms instead of measuring only a decrease in falls, Robyn Karnauskas, an analyst with Deutsche Bank Securities in New York. wrote in a note to clients today.

    Another trial may cause a two-year delay and lead to a late 2014 product introduction,
     
  10. Anonymous

    Anonymous Guest

    Finally a great post! Thank you for sharing. Everyone needs to WAKE UP. This is a deadend and you need to find something else!




    QUOTE=Anonymous;4314983]READ THis and SHUT THE FUCK UP-STUPID


    Chelsea Therapeutics International Ltd. (CHTP) fell as much as 29 percent after failing to get the U.S. regulatory approval needed to bring its first drug to market.

    The Food and Drug Administration wants more data on Northera, a medicine intended to treat a cause of dizziness and fainting in people with nervous-system disorders, Chelsea said in a statement yesterday. Chelsea tumbled 29 percent to $2.62 at the close in New York, the biggest single-day decline since Feb. 13.

    The FDA requested information from an additional study of Northera, which can curb drops in blood pressure, Chelsea said. The Charlotte, North Carolina-based company said it’s conducting a clinical trial that may provide the additional data about the drug’s “efficacy and durability” sought by the FDA.

    The trial “may not be sufficient for approval” because the FDA is likely to ask for more information about a range of symptoms instead of measuring only a decrease in falls, Robyn Karnauskas, an analyst with Deutsche Bank Securities in New York. wrote in a note to clients today.

    Another trial may cause a two-year delay and lead to a late 2014 product introduction,[/QUOTE]
     
  11. Anonymous

    Anonymous Guest

    What company cars are they giving?
     
  12. Anonymous

    Anonymous Guest

    I hope you are joking! What don't you understand about non-approval? No drug, no reps, no company cars. Move on!!!!
     
  13. Anonymous

    Anonymous Guest

    would they still honor the same choices?? that is all i want to know? In six months can i still get the same car? Will the terriotires change??
     
  14. Anonymous

    Anonymous Guest

    Car allowance
     
  15. Anonymous

    Anonymous Guest

    Stop being a trouble maker and throwing salt in the wound. Everyone knows nothing will happen as soon as 6 months. Haven't you read any of the articles? In addition, this was a start up company and they have no money for fleet vehicles. This opportunity isn't going to happen. Simple as that.
     
  16. Anonymous

    Anonymous Guest

    They habpve not met with the FDA yet to see what they want. Until then all is speculation.
     
  17. Anonymous

    Anonymous Guest

    Give it up! The party is over
     
  18. Anonymous

    Anonymous Guest

    WHEN WILL THEY START TO INTERVIEW AGAIN?? STILL HAVE NOT HEARD MORE AFTER BEING TOLD I WAS ONE OF THE BEST CANDIDATES?????
     
  19. Anonymous

    Anonymous Guest

    Please stop....you are not even remotely funny. No jobs and even if the drug would get approved, it will be 2 years or more.
     
  20. Anonymous

    Anonymous Guest

    are you stupid?????? Cant you read the posts?????

    Why dont you call the head office and complain????